Interferon alpha-2

Preferred Label : Interferon alpha-2;

MeSH definition : Alpha interferons encoded by the human IFNA2 gene. Recombinant forms are used in the treatment of CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; KAPOSI SARCOMA; MELANOMA; and HAIRY CELL LEUKEMIA.; Alpha interferon encoded by the human IFNA2 gene. Recombinant forms are used in the treatment of CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; KAPOSI SARCOMA; MELANOMA; and HAIRY CELL LEUKEMIA.;

MeSH synonym : Interferon alpha 2; Interferon-alpha 2; Interferon alpha-A; Interferon alpha A; LeIF A; IFN-alpha 2; IFN-alpha-2;

MeSH hyponym : Interferon alfa 2a; Recombinant Interferon alpha-2a; Interferon alpha-2a, Recombinant; Recombinant Interferon alpha 2a; Roferon A; RoferonA; Ro 22 8181; Ro 228181; Sch 30500; Sch30500; Interferon alfa 2b; Interferon alpha-2b, Recombinant; Interferon alpha 2b, Recombinant; Recombinant Interferon alpha-2b; Recombinant Interferon alpha 2b; IFNalpha-2b, Recombinant; IFNalpha 2b, Recombinant; Recombinant IFNalpha-2b;

MeSH Related Number : 43K1W2T1M6; 47RRR83SK7; 76543-88-9 (interferon alfa-2a); 99210-65-8 (interferon alfa-2b);

Details

Origin ID

D000077190;

UMLS CUI

C2937361;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Pharmacological action(s)
- antineoplastic agents [MeSH Descriptor]
- antiviral agents [MeSH Descriptor]
Record concept(s)
- Interferon Alfa-2a [MeSH concept]
- Interferon Alfa-2b [MeSH concept]
- Intron A (Interferon) [MeSH concept]
- Ro 22-8181 [MeSH concept]
- Roferon-A [MeSH concept]
- Sch-30500 [MeSH concept]
- interferon alpha-2 [MeSH concept]
- reaferon [MeSH concept]
- viferon [MeSH concept]
Related MeSH Supplementary Concept(s)
- Interferon-alpha2b [MeSH Supplementary Concept]
- peginterferon alfa-2b [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
UMLS correspondences (same concept)
- Interferon alfa-2a (substance) [SNOMED CT concept]
- Interferon alfa-2b (substance) [SNOMED CT concept]
- Product containing interferon alfa-2a (medicinal product) [SNOMED CT concept]
- Product containing interferon alfa-2b (medicinal product) [SNOMED CT concept]
- Recombinant Interferon Alfa-2a [NCIt concept]
- Recombinant Interferon Alfa-2b [NCIt concept]
- interferon alfa-2a [ATC Code]
- interferon alfa-2b [ATC Code]
Validated automatic mappings to BTNT
- Interferon alfa-2a (substance) [SNOMED CT concept]
- Interferon alfa-2b (substance) [SNOMED CT concept]
- interferon alfa-2a [ATC Code]
- interferon alfa-2b [ATC Code]
Validated automatic mappings to NTBT
- Interferon alfa (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients